Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen

Predictors Of Outcome ◽

Adrenal Androgen ◽

Castration Resistant ◽

Androgen Levels ◽

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel

Frontiers in Pharmacology ◽

10.3389/fphar.2017.00836 ◽

2017 ◽

Vol 8 ◽

Author(s):

Jian-Ri Li ◽

Kun-Yuan Chiu ◽

Shian-Shiang Wang ◽

Cheng-Kuang Yang ◽

Chuan-Shu Chen ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)

BMC Cancer ◽

10.1186/s12885-019-5526-3 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 4

Author(s):

Taro Iguchi ◽

Satoshi Tamada ◽

Minoru Kato ◽

Sayaka Yasuda ◽

Takeshi Yamasaki ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Study Protocol ◽

Phase Ii Trial ◽

Castration Resistant ◽

Randomized Phase Ii ◽

Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5172 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5172-5172 ◽

Cited By ~ 3

Author(s):

G. Sonpavde ◽

A. M. Aparicio ◽

R. Delaune ◽

L. E. Garbo ◽

S. R. Rousey ◽

...

Keyword(s):

Prostate Cancer ◽

Castration Resistant ◽

Combined Androgen Blockade Revisited: Emerging Options for the Treatment of Castration-Resistant Prostate Cancer

Urology ◽

10.1016/j.urology.2008.09.040 ◽

2009 ◽

Vol 73 (4) ◽

pp. 697-705 ◽

Cited By ~ 8

Author(s):

Matthew N. Simmons ◽

Eric A. Klein

Keyword(s):

Prostate Cancer ◽

Castration Resistant ◽

Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade

Prostate International ◽

10.1016/j.prnil.2017.07.001 ◽

2018 ◽

Vol 6 (1) ◽

pp. 18-23 ◽

Cited By ~ 5

Author(s):

Takashi Nagai ◽

Taku Naiki ◽

Keitaro Iida ◽

Toshiki Etani ◽

Ryosuke Ando ◽

...

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Castration Resistant ◽

SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies

Journal of the Endocrine Society ◽

10.1210/js.2019-sat-lb002 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

Author(s):

Gido Snaterse ◽

Lisanne van Dessel ◽

Angela Taylor ◽

Jenny Visser ◽

Wiebke Arlt ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Second Line ◽

Metabolome Analysis ◽

Castration Resistant

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study

International Journal of Clinical Oncology ◽

10.1007/s10147-019-01554-3 ◽

2019 ◽

Vol 25 (3) ◽

pp. 486-494

Author(s):

Taro Iguchi ◽

Satoshi Tamada ◽

Minoru Kato ◽

Sayaka Yasuda ◽

Yuichi Machida ◽

...

Keyword(s):

Prostate Cancer ◽

Castration Resistant ◽

PROSTATE-SPECIFIC ANTIGEN RESPONSE TO DEFERRED COMBINED ANDROGEN BLOCKADE THERAPY USING BICALUTAMIDE PREDICTS SURVIVAL AFTER SUBSEQUENT OESTROGEN AND DOCETAXEL THERAPIES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

BJU International ◽

10.1111/j.1464-410x.2012.11061.x ◽

2012 ◽

Vol 110 (8) ◽

pp. 1155-1155 ◽

Cited By ~ 1

Author(s):

Marc B. Garnick

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Castration Resistant ◽

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer

Oncotarget ◽

10.18632/oncotarget.26426 ◽

2018 ◽

Vol 9 (97) ◽

pp. 36966-36974 ◽

Cited By ~ 4

Author(s):

Satoshi Tamada ◽

Taro Iguchi ◽

Minoru Kato ◽

Jumpei Asakawa ◽

Kazuaki Kita ◽

...

Keyword(s):

Prostate Cancer ◽

Time To Progression ◽

Castration Resistant ◽

Hormone Sensitive ◽

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer

BJU International ◽

10.1111/j.1464-410x.2012.10959.x ◽

2012 ◽

Vol 110 (8) ◽

pp. 1149-1155 ◽

Cited By ~ 6

Author(s):

Toshiki Kijima ◽

Yasuhisa Fujii ◽

Minato Yokoyama ◽

Junichiro Ishioka ◽

Yoh Matsuoka ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Castration Resistant ◽